Member Info for Dazpink

This was taken from last year results. The business is solid and growing, this is why Sidara want it

*Strategic progress and strong growth in the first year of our strategy

*Delivered results in line with expectations

*Revenue growth across all business units

*Strong adjusted EBITDA growth, in line with guidance

*Continued momentum

*Fastest growth in Consulting and across sustainable solutions

*Order book up 4% to $6.3 billion, up 7% like-for-like14

*Double-digit growth in our factored sales pipeline

*Improving pricing trends across pipeline, order book and in margin performance in 2023

*Adjusted operating cash flow improved to $194 million, up $260 million on last year

*Growing our sustainable solutions business to $1.3 billion15

*Sustainable solutions revenue up 15% and represented 22% of Group revenue

*43% of factored sales pipeline now in sustainable solutions

Monty,

We are now in good hands, Iain Torrens has joined as interim chief financial officer, he also joining the board as an executive director.

He brings to the table three decades of finance experience, which to me means he has seen this situation many times before.

He will be able to scrutinise financials that were in the hands of Arvind Balan (having resigned due to him being caught out). Ian and his team will more then likely do creative accounting to demonstrate to the board that the market panicked Earlier in February when Wood disappointed investors with an underwhelming trading update for 2024, stating it would be cashflow negative to the tune of between $150 million and $250 million this year.

For me the market has over reacted, same thing happened with Rolls Royce, new CEO new CFO and boom it Rocketed !

Wood subsequently received a non-binding, conditional proposal from Sidara related to a possible cash offer for the Company.

My thoughts are If the cash offer was below £1.50 would Ken Gilmartin and the board allow Sidara access to confidential information as per the statement below released by WG

I would have expected them to tell them to come back in 6 - 12 months if it was less than £1.50

On 24 February 2025, Wood announced that it had received an approach from Dar Al-Handasah Consultants Shair and Partners Holdings Ltd ("Sidara") in relation to a possible cash offer for the entire issued and to be issued share capital of the Company.

Wood subsequently received a non-binding, conditional proposal from Sidara related to a possible cash offer for the Company. Following this, Wood provided Sidara with access to due diligence information and entered into discussions with Sidara.

Hi, Agree island girl, I am happy I bought plenty yesterday, if no deal, I really don’t mind waiting until next year to see it boom to £2 or more.

Apollo Global Management, Sidara or others will come for it then and pay more. Simple as that, patience is key here

HelloDave, goodbye Dave

Dropping out is no big deal, can be short term and has happened to many other leading companies.

Rolls Royce dropped out of it 3 years ago, in Jan 2023 Tufan the new CEO brought in when Warren East left Rolls-Royce described the engineering giant as a "burning platform" he said that the company's performance is "unsustainable. The price back then was 0.80p now worth £8 as share.

Now a top FTSE 100 company worth 40 billion

Meant to add instead of losing it later to an American VC fund.

Https://sidaracollaborative.com/

We are a collaborative of specialist firms uniquely positioned to deliver comprehensive and collective solutions for the world’s biggest, most ambitious, and most critical challenges.

The cost to acquire WG is small change to Sidara Dar Al-Handasah Consultants Shair and Partners Holdings Ltd, the global brand name is huge

Soon John Woods Group will be among this list,

Bought plenty today, sold other shares to buy these at a great price. Prepared to wait if company is sold, if not, 2026 looks good on the business update last month, happy to wait to make a good return.

Other potential buyers could be interested while Sidara makes up its mind.

Dallo

Feel your pain, 6 years invested wow, my holding is 100,000, it was more but made the decision awhile back to divert a large amount into another company that I am following to reduce the risk. The only thing that keeps me here is the opportunity of making double from a buyer who sees the potential of PureTech.

I struggle to understand how the people at the top remain in position, the strategy that is currently on the table isn’t working

Large trade today ?

Agree Saint68, when the consolidation happened 400:1 to become £4 we trusted them to manage this going forward with a strategy to show potential investors that Hemo had stepped up to become not only a clinical company but also a company that has good financial management so that anyone’s investment is now in good hands. Both Vlad and Redmond have lost the trust of every investor now

15p drop to £1.69 how does this happen after RNS update on second patient. Vlad and Redmond must be panicking, this could go to sub £1 if any delays or negative news comes in

Tuan6, back in the Covid days, many companies thought about get rich quick schemes, Hemo though this probably be a good thing back then, more then likely realised this would cause too much diversification with little resource and zero funds and focused on the gems that are in the pipeline CAR-T, CDX and CBR. Glad it made this decision !

Very poor communication and PR. The salary for the senior management team must be huge, anyone who buys PureTech will immediately place most of them on 3 months gardening leave with a NDA, clear the deck

What was really annoying for me was listening to the interview with Stephen Gunnion on Proactive Investors on December 16th which is only 12 weeks ago

non-executive director Peter Redmond Redmond explained the reasoning behind the consolidation, aimed at attracting institutional investors and enhancing the company’s capital structure as it moves closer to clinical trials for its HEMO-CAR-T lead therapy.

He went on about how the 400-to-1 share consolidation, was intended to attract serious institutional investors and needed to be priced at a decent price to attract them.

He needs to be re-interviewed and explain to all why

Hard to understand, especially when Redmond explained in his interview on Proactive Investors that the recent 400-to-1 share consolidation was intended to attract serious institutional investors at a more acceptable share price.

AstraZeneca is to acquire Belgium-based EsoBiotec, a leading in vivo cell therapy company, in a deal worth up to $1 billion.

EsoBiotec’s platform empowers the immune system to attack cancers and could offer many more patients access to transformative cell therapy treatments delivered in just minutes rather than the current process which takes weeks.

AstraZeneca executive vice president Susan Galbraith said: “We are excited about the acquisition of EsoBiotec and the opportunity to rapidly advance their promising in vivo platform.

“We believe it has the potential to transform cell therapy and will enable us to scale these innovative treatments so that many more patients around the world can access them.

“EsoBiotec will accelerate and expand the impact of our recent investments and marks a major step forward in realising our ambition to harness the full potential of cell therapy.”

AstraZeneca will acquire EsoBiotec for a total consideration of up to $1billion, on a cash and debt free basis.

This will include an initial payment of $425 million on deal closing, and up to $575 million based on development and regulatory milestones.

TruroTrader

Facts are cargo ship hit a the U.S.-flagged chemical and oil products tanker MV Stena, the tanker was transporting jet fuel for the U.S. military which is classed as sensitive cargo

Sensitive Cargo: Definition and Scope

Sensitive cargo refers to goods that require special attention and handling during international transportation. These items are neither outright prohibited nor equivalent to general cargo, but they lie somewhere in between, possessing certain unique characteristics and risks. Such cargo may involve aspects of biosecurity, environmental protection, cultural preservation, and intellectual property rights protection, necessitating strict compliance with relevant laws and regulations, along with special measures to ensure safety.

There are so, so many countries around the world that need to monitor their coastlines, with IUU fishing being one of the drivers. China is a major aggressor as it hoovers up fish stocks around the world. The other driver is the need to monitor coastal waters for illegal activities including smuggling (Guns, drugs and people). I suspect that many countries are looking at SRT, with the company receiving numerous inquiries. The limiting factor is the funding. Obviously oil rich counties have ready cash , but others will need to borrow using UKEF. I get the impression that UKEF now understands the SRT offering and has confidence to help on numerous fronts. How fast can SRT grow? I am hoping for contract news from Kuwait and Saudi Arabia in the next few months. I am also hoping that Tanzania and Kenya can borrow the necessary funds. If Australia puts its toe in the water it could start around the northern territories. I imagine that New Zealand has a similar problem. Simon has always said that competition will eventually arrive, but for the time being it has the market to itself. Finally there is the growing threat of underwater and surface drones, which are the new dimension of warfare with their ability to attack underwater cables and pipelines. At some stage the market is going to wake up to what SRT represents. However, I suspect that there are major defence contractors trying to decide how to capture this little company based in Somerset. Interesting and exciting times, especially since the company is now awash with cash.